Six-month review of weight and metabolic parameters in patients receiving clozapine, risperidone, olanzapine, or quetiapine

被引：10
|
作者：
Kelly, DL [1 ]
Kreyenbuhl, J [1 ]
Love, RC [1 ]
Van-Duong, Q [1 ]
Conley, RR [1 ]
机构：
[1] Univ Maryland, Baltimore, MD 21201 USA
来源：
JOURNAL OF CLINICAL PSYCHIATRY | 2003年 / 64卷 / 09期
关键词：
D O I：
10.4088/JCP.v64n0921f
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：1133 / 1134
页数：2
相关论文
共 50 条
  • [41] Change in clinical status and side effects of patients treated with either olanzapine or risperidone:: Six-month results from the three-year intercontinental schizophrenia outpatient health outcomes (IC-SOHO) observational study
    Gargoloff, PR
    O'Halloran, RA
    Boland, JM
    Brunner, E
    Dossenbach, M
    Levitt, L
    Valencia, A
    Landa, E
    González, C
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 283 - 284
  • [42] TNF-α-308 G>A polymorphism and weight gain in patients with schizophrenia under long-term clozapine, risperidone or olanzapine treatment
    Huang, Hsiang-Hsuan
    Wang, Ying-Chieh
    Wu, Chia-Liang
    Hong, Chen-Jee
    Bai, Ya-Mei
    Tsai, Shih-Jen
    Liou, Ying-Jay
    NEUROSCIENCE LETTERS, 2011, 504 (03) : 277 - 280
  • [43] Impact of adalimumab on erectile dysfunction, sperm parameters and hormonal profile in male psoriasis patients: a six-month observational study
    Yuksek, Tugcan
    Atas, Hatice
    Kartal, Selda Pelin
    Aygar, Gamze Tas
    Karakoyunlu, Ahmet Nihat
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 317 (01)
  • [44] A 12-Month Randomized, Open-Label Study of the Metabolic Effects of Olanzapine and Risperidone in Psychotic Patients: Influence of Valproic Acid Augmentation
    Meltzer, Herbert Y.
    Bonaccorso, Stefania
    Bobo, William V.
    Chen, Yuejin
    Jayathilake, Karuna
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (12) : 1602 - 1610
  • [45] Six-Month Morbidity and Mortality among Intensive Care Unit Patients Receiving Life-Sustaining Therapy A Prospective Cohort Study
    Detsky, Michael E.
    Harhay, Michael O.
    Bayard, Dominique F.
    Delman, Aaron M.
    Buehler, Anna E.
    Kent, Saida A.
    Ciuffetelli, Isabella V.
    Cooney, Elizabeth
    Gabler, Nicole B.
    Ratcliffe, Sarah J.
    Mikkelsen, Mark E.
    Halpern, Scott D.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2017, 14 (10) : 1562 - 1570
  • [46] Evaluation of weight and metabolic parameters after switching from olanzapine to aripiprazole: a clinical case series of bipolar patients
    Ercan, A. C.
    Altinbas, K.
    Kurt, E.
    BIPOLAR DISORDERS, 2012, 14 : 71 - 72
  • [47] Six-month progression-free survival as an alternative primary efficacy endpoint to overall survival in newly diagnosed glioblastoma patients receiving temozolomide
    Polley, Mei-Yin C.
    Lamborn, Kathleen R.
    Chang, Susan M.
    Butowski, Nicholas
    Clarke, Jennifer L.
    Prados, Michael
    NEURO-ONCOLOGY, 2010, 12 (03) : 274 - 282
  • [48] A six-month, double-blind, controlled trial in. schizophrenic patients comparing amisulpride and olanzapine. Preliminary results on short-term analysis
    Martins, S
    Loo, H
    Peuskens, J
    Rein, W
    Fleurot, O
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S329 - S330
  • [49] Six-Month Low-Dose Valganciclovir Prophylaxis in Cytomegalovirus D+/R- Kidney Transplant Patients Receiving Thymoglobulin Induction
    Luan, F. L.
    TRANSPLANTATION PROCEEDINGS, 2013, 45 (01) : 175 - 177
  • [50] A Retrospective Review of the Cognitive Profile of Post-Stroke Patients within an Acute Irish Setting over a Six-Month Period
    Mc Nally, Sarah
    Crowe, Morgan
    Noone, Imelda
    IRISH JOURNAL OF MEDICAL SCIENCE, 2014, 183 : S353 - S353
12345